|
Otitis media with effusion: comparative effectiveness of treatments |
Berkman ND, Wallace IF, Steiner MJ, Harrison M, Greenblatt AM, Lohr KN, Kimple A, Yuen A |
|
|
Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Berkman ND, Wallace IF, Steiner MJ, Harrison M, Greenblatt AM, Lohr KN, Kimple A, Yuen A. Otitis media with effusion: comparative effectiveness of treatments. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 101. 2013 Authors' objectives To compare benefits and harms of strategies currently in use for managing otitis media with effusion (OME). Treatment for OME may include single approaches alone or combinations of two or more approaches. We compared benefits and harms among these treatments: tympanostomy tubes (TT), myringotomy (myr), adenoidectomy (adenoid), autoinflation (auto), oral or nasal steroids, complementary and alternative medicine (CAM), and watchful waiting (WW). We included comparisons of treatment effectiveness in subgroups of patients with OME, and whether outcome differences were related to factors affecting health care delivery or the receipt of pneumococcal vaccine inoculation. Authors' conclusions There is evidence that both TT and adenoid reduce OME and improve hearing in the short term, but both treatments also have associated harms. Large, well-controlled studies could help resolve the risk-benefit ratio by measuring AOM recurrence, functional outcomes, quality of life measures, and long-term outcomes. Finally, additional research is needed to support treatment decisions in subpopulations, particularly those with comorbidities and those who have received a pneumococcal vaccine inoculation. Indexing Status Subject indexing assigned by CRD MeSH Otitis Media with Effusions Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence AHRQ, Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA Email: AHRQTAP@ahrq.hhs.gov AccessionNumber 32013000733 Date abstract record published 14/10/2013 |
|
|
|